Zkusit zdarma
Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

MCRB
Cena:
$ 7.92
-0.13 (-1.61%)
Valuace
53
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference

Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference

7:00 12-05-2026

CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a lead...

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

7:00 05-05-2026

Clinical readout from investigator-sponsored SER-155 study in immune checkpoint inhibitor-related en...

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

7:00 04-05-2026

Data highlight both SER-603's rational design that targets microbial functions linked to mucosal hea...

Seres Therapeutics to Present at CARB-X Investor Day

Seres Therapeutics to Present at CARB-X Investor Day

7:00 09-04-2026

CAMBRIDGE, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres...

Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

7:00 12-03-2026

Readout of investigator-sponsored SER-155 study in immune checkpoint–related enterocolitis, a freq...

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

11:12 03-03-2026

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome ...

Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash

Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash

8:29 12-02-2026

Seres Therapeutics Inc. (NASDAQ: MCRB) shares are down during Thursday's premarket session following...

Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

7:00 12-02-2026

Seres has finalized the protocol for the Phase 2 study of SER-155 in patients undergoing allogeneic ...

Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving Average – Time to Sell?

Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving Average – Time to Sell?

4:20 11-02-2026

Shares of Seres Therapeutics, Inc. (NASDAQ: MCRB - Get Free Report) crossed below its 50-day moving ...

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving Average – Time to Sell?

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving Average – Time to Sell?

4:52 16-01-2026

Seres Therapeutics, Inc. (NASDAQ: MCRB - Get Free Report) crossed below its fifty day moving average...

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

7:00 06-01-2026

Data demonstrate  clinical translation of VOWST mechanisms of action in both first and multiply rec...

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving Average – Here’s What Happened

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving Average – Here’s What Happened

4:14 05-12-2025

Seres Therapeutics, Inc. (NASDAQ: MCRB - Get Free Report)'s share price crossed below its 50 day mov...

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

7:00 24-11-2025

CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a lea...

Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call Transcript

14:11 05-11-2025

Seres Therapeutics, Inc. ( MCRB ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Partici...

Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

7:00 05-11-2025

Following constructive FDA feedback, Seres is finalizing its SER-155 Phase 2 study protocol for the ...

Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025

Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025

7:00 30-10-2025

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a lea...

All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy

All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy

13:01 09-09-2025

Seres Therapeutics (MCRB) might move higher on growing optimism about its earnings prospects, which ...

Seres Therapeutics (MCRB)'s Technical Outlook is Bright After Key Golden Cross

Seres Therapeutics (MCRB)'s Technical Outlook is Bright After Key Golden Cross

10:56 28-08-2025

After reaching an important support level, Seres Therapeutics, Inc. (MCRB) could be a good stock pic...

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

21:47 06-08-2025

Seres Therapeutics, Inc. (NASDAQ:MCRB ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET C...

Seres (MCRB) Q2 Loss Narrows 34%

Seres (MCRB) Q2 Loss Narrows 34%

21:23 06-08-2025

Seres (MCRB) Q2 Loss Narrows 34%...

close

SERES PROVIDES PROGRAM AND CORPORATE UPDATES AND PRIORITIZES EMERGING PROGRAMS IN INFLAMMATORY & IMMUNE DISEASES

12-02-2026
SERES HAS FINALIZED THE PROTOCOL FOR THE PHASE 2 STUDY OF SER-155 IN PATIENTS UNDERGOING ALLOGENEIC ...
Více zde

SERES THERAPEUTICS ANNOUNCES PUBLICATIONS IN NATURE MEDICINE AND JOURNAL OF INFECTIOUS DISEASES HIGHLIGHTING VOWST™ MECHANISM OF ACTION AND SUPPORTING BROADER LIVE BIOTHERAPEUTIC STRATEGY

06-01-2026
DATA DEMONSTRATE  CLINICAL TRANSLATION OF VOWST MECHANISMS OF ACTION IN BOTH FIRST AND MULTIPLY REC...
Více zde

SERES THERAPEUTICS TO PARTICIPATE IN PIPER SANDLER HEALTHCARE CONFERENCE

24-11-2025
CAMBRIDGE, MASS., NOV. 24, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

05-11-2025
FOLLOWING CONSTRUCTIVE FDA FEEDBACK, SERES IS FINALIZING ITS SER-155 PHASE 2 STUDY PROTOCOL FOR THE ...
Více zde

SERES THERAPEUTICS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES ON NOVEMBER 5, 2025

30-10-2025
CAMBRIDGE, MASS., OCT. 30, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS RECEIVES AWARD OF UP TO $3.6 MILLION FROM CARB-X TO DEVELOP LIQUID FORMULATION OF SER-155

29-10-2025
LIQUID FORMULATION HAS POTENTIAL TO EXPAND PATIENT ACCESS, INCLUDING THOSE IN INTENSIVE CARE, TO SER...
Více zde

SERES THERAPEUTICS TO PRESENT NEW POST HOC DATA FROM SER-155 PHASE 1B TRIAL AT IDWEEK 2025, HIGHLIGHTING POTENTIAL TO IMPROVE OUTCOMES IN ADULTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT

14-10-2025
CAMBRIDGE, MASS. , OCT. 14, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), (SERES...
Více zde

SERES THERAPEUTICS ANNOUNCES FURTHER CONSTRUCTIVE FEEDBACK FROM FDA ON SER-155 PHASE 2 STUDY PROTOCOL AND IMPLEMENTS COST REDUCTION ACTIONS TO EXTEND CASH RUNWAY

23-09-2025
FOLLOWING RECENT CONSTRUCTIVE FDA FEEDBACK, SERES ANTICIPATES FINALIZING SER-155 PHASE 2 STUDY PROTO...
Více zde

SERES THERAPEUTICS TO PARTICIPATE IN H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

27-08-2025
CAMBRIDGE, MASS., AUG. 27, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

06-08-2025
FOLLOWING FDA INPUT, SERES SUBMITTED PHASE 2 STUDY PROTOCOL TO FDA FOR SER-155 FOR THE PREVENTION OF...
Více zde

SERES THERAPEUTICS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES ON AUGUST 6, 2025

22-07-2025
CAMBRIDGE, MASS., JULY 22, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS PRESENTS EXPANDED SER-155 EXPLORATORY BIOMARKER DATA AT 2025 ASCO ANNUAL MEETING

27-05-2025
RESULTS HIGHLIGHT POTENTIAL ROLE OF SER-155 IN PROMOTING PERIPHERAL T-CELL RECOVERY AND IMMUNE RECON...
Více zde

SERES THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

07-05-2025
IN LINE WITH RECENT FDA FEEDBACK, SERES EXPECTS TO SUBMIT A PHASE 2 STUDY PROTOCOL TO FDA IN THE COM...
Více zde

SERES THERAPEUTICS PRESENTS DATA AT THE 2025 DIGESTIVE DISEASE WEEK CONFERENCE HIGHLIGHTING THE POTENTIAL FOR LIVE BIOTHERAPEUTICS TO TREAT INFLAMMATORY AND IMMUNE DISEASES

29-04-2025
CAMBRIDGE, MASS., APRIL 29, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES ON MAY 7, 2025

23-04-2025
CAMBRIDGE, MASS., APRIL 23, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LE...
Více zde

SERES THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

13-03-2025
RECENT FDA FEEDBACK RECEIVED ON SER-155 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) NE...
Více zde

SERES THERAPEUTICS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATES ON MARCH 13, 2025

04-03-2025
CAMBRIDGE, MASS., MARCH 04, 2025 (GLOBE NEWSWIRE) --  SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A...
Více zde

SERES THERAPEUTICS RECEIVES FEEDBACK FROM FDA ON SER-155 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) DEVELOPMENT APPROACH

03-03-2025
FDA HAS PROVIDED INPUT ON KEY ELEMENTS OF THE SER-155 ALLO-HSCT CLINICAL DEVELOPMENT PLANS INCLUDING...
Více zde

SERES THERAPEUTICS ANNOUNCES RECEIPT OF EXPECTED $50 MILLION INSTALLMENT PAYMENT RELATED TO VOWST SALE

16-01-2025
CAMBRIDGE, MASS., JAN. 16, 2025 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB) (SERES O...
Více zde

SERES THERAPEUTICS ANNOUNCES NEW TRANSLATIONAL BIOMARKER RESULTS FROM SER-155 PHASE 1B CLINICAL STUDY AND PROVIDES CORPORATE UPDATES

09-01-2025
NEW SER-155 PHASE 1B STUDY BIOMARKER DATA IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALL...
Více zde

SERES THERAPEUTICS TO PARTICIPATE IN 2025 J.P. MORGAN HEALTHCARE CONFERENCE

16-12-2024
CAMBRIDGE, MASS., DEC. 16, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEADI...
Více zde

SERES THERAPEUTICS TO PARTICIPATE IN PIPER SANDLER HEALTHCARE CONFERENCE

22-11-2024
CAMBRIDGE, MASS., NOV. 22, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEADI...
Více zde

SERES THERAPEUTICS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS UPDATES ON NOVEMBER 13, 2024

06-11-2024
CAMBRIDGE, MASS., NOV. 06, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEA...
Více zde

SERES THERAPEUTICS ANNOUNCES COMPLETION OF VOWST™ ASSET SALE TO SOCIÉTÉ DES PRODUITS NESTLÉ S.A

30-09-2024
TRANSACTION SUPPORTS FURTHER DEVELOPMENT OF SER-155, FOLLOWING RECENT PROMISING CLINICAL DATA, AND O...
Více zde

SERES THERAPEUTICS STOCKHOLDERS ISSUE OPEN LETTER TO BOARD OF DIRECTORS REGARDING REPORTED ENGAGEMENT WITH NESTLÉ

27-09-2024
GENEVA--(BUSINESS WIRE)--LUCIEN SELCE AND MKT CAPITAL LTD. (TOGETHER, “WE”), WHO COLLECTIVELY OW...
Více zde

SERES THERAPEUTICS STOCKHOLDERS APPROVE SALE OF VOWST™ TO NESTLÉ HEALTH SCIENCE; SALE EXPECTED TO CLOSE ON SEPTEMBER 30

26-09-2024
CAMBRIDGE, MASS., SEPT. 26, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), (“S...
Více zde

SERES THERAPEUTICS TO PARTICIPATE IN CANTOR 2024 GLOBAL HEALTHCARE CONFERENCE

13-09-2024
CAMBRIDGE, MASS., SEPT. 13, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB), A LEAD...
Více zde

SERES THERAPEUTICS REPORTS SER-155 PHASE 1B PLACEBO-CONTROLLED COHORT 2 STUDY SAFETY AND CLINICAL RESULTS IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

12-09-2024
SER-155 ADMINISTRATION WAS ASSOCIATED WITH A SIGNIFICANT REDUCTION IN BOTH BACTERIAL BLOODSTREAM INF...
Více zde

SERES THERAPEUTICS ANNOUNCES SIGNING OF VOWST™ ASSET PURCHASE AGREEMENT WITH NESTLÉ HEALTH SCIENCE

06-08-2024
UPON CLOSING, SERES TO RECEIVE $175M CASH INFUSION, INCLUDING AN UPFRONT PAYMENT, PREPAYMENT OF A FU...
Více zde

SERES THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-06-2024
CAMBRIDGE, MASS, JUNE 07, 2024 (GLOBE NEWSWIRE) -- SERES THERAPEUTICS, INC. (NASDAQ: MCRB) (“SERES...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-10-03 01:00:008-KStáhnout
2025-10-03 00:00:008-KStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-05-07 01:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:008-KStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-04-22 01:00:008-KStáhnout
2025-04-22 00:00:008-KStáhnout
2025-04-14 01:00:008-KStáhnout
2025-04-14 00:00:008-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-13 00:00:0010-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-12 23:00:0010-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-06 00:00:008-KStáhnout
2025-02-05 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-11-13 00:00:008-KStáhnout
2024-11-13 00:00:0010-QStáhnout
2024-11-12 23:00:008-KStáhnout
2024-11-12 23:00:0010-QStáhnout
2024-10-01 01:00:008-KStáhnout
2024-10-01 00:00:008-KStáhnout
2024-09-26 01:00:008-KStáhnout
2024-09-26 00:00:008-KStáhnout
2024-09-12 01:00:008-KStáhnout
2024-09-12 00:00:008-KStáhnout
2024-08-15 01:00:008-KStáhnout
2024-08-15 00:00:008-KStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 00:00:008-KStáhnout
2024-04-23 01:00:008-KStáhnout
2024-04-23 00:00:008-KStáhnout
2024-04-08 01:00:008-KStáhnout
2024-04-08 00:00:008-KStáhnout
2024-03-05 00:00:008-KStáhnout
2024-03-05 00:00:0010-KStáhnout
2024-03-04 23:00:008-KStáhnout
2024-03-04 23:00:0010-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-01-30 00:00:008-KStáhnout
2024-01-29 23:00:008-KStáhnout
2024-01-10 00:00:008-KStáhnout
2024-01-09 23:00:008-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2024-01-02 00:00:008-KStáhnout
2024-01-01 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-04 01:00:008-KStáhnout
2023-10-04 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-28 01:00:008-KStáhnout
2023-06-28 00:00:008-KStáhnout
2023-06-23 01:00:008-KStáhnout
2023-06-23 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-03-07 00:00:008-KStáhnout
2023-03-07 00:00:0010-KStáhnout
2023-03-06 23:00:008-KStáhnout
2023-03-06 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-12-14 00:00:008-KStáhnout
2022-12-13 23:00:008-KStáhnout
2022-11-02 00:00:008-KStáhnout
2022-11-02 00:00:0010-QStáhnout
2022-11-01 23:00:008-KStáhnout
2022-11-01 23:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-04-06 01:00:008-KStáhnout
2022-04-06 00:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 01:00:0010-QStáhnout
2021-08-03 00:00:008-KStáhnout
2021-08-03 00:00:0010-QStáhnout
2021-07-22 01:00:008-KStáhnout
2021-07-22 00:00:008-KStáhnout
2021-07-01 01:00:008-KStáhnout
2021-07-01 00:00:008-KStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-05-21 01:00:008-KStáhnout
2021-05-21 00:00:008-KStáhnout
2021-05-20 01:00:008-KStáhnout
2021-05-20 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-03-02 00:00:008-KStáhnout
2021-03-02 00:00:0010-KStáhnout
2021-03-01 23:00:008-KStáhnout
2021-03-01 23:00:0010-KStáhnout
2021-02-01 00:00:008-KStáhnout
2021-01-31 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-07 00:00:008-KStáhnout
2020-12-06 23:00:008-KStáhnout
2020-11-20 00:00:008-KStáhnout
2020-11-19 23:00:008-KStáhnout
2020-11-09 00:00:0010-QStáhnout
2020-11-08 23:00:0010-QStáhnout
2020-08-14 01:00:008-KStáhnout
2020-08-14 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 00:00:008-KStáhnout
2020-07-28 01:00:0010-QStáhnout
2020-07-28 00:00:0010-QStáhnout
2020-06-22 01:00:008-KStáhnout
2020-06-22 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-23 00:00:008-KStáhnout
2020-03-22 23:00:008-KStáhnout
2020-03-18 00:00:008-KStáhnout
2020-03-17 23:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-02 00:00:0010-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-03-01 23:00:0010-KStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-11-27 00:00:008-KStáhnout
2019-11-26 23:00:008-KStáhnout
2019-11-05 00:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:008-KStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-11-04 00:00:008-KStáhnout
2019-11-03 23:00:008-KStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 01:00:0010-QStáhnout
2019-08-06 00:00:008-KStáhnout
2019-08-06 00:00:0010-QStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 00:00:008-KStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:008-KStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-04-18 01:00:008-KStáhnout
2019-04-18 00:00:008-KStáhnout
2019-03-11 00:00:008-KStáhnout
2019-03-10 23:00:008-KStáhnout
2019-03-06 00:00:008-KStáhnout
2019-03-06 00:00:0010-KStáhnout
2019-03-05 23:00:008-KStáhnout
2019-03-05 23:00:0010-KStáhnout
2019-01-15 00:00:008-KStáhnout
2019-01-14 23:00:008-KStáhnout
2018-11-21 00:00:008-KStáhnout
2018-11-20 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-06 23:00:008-KStáhnout
2018-10-22 01:00:008-KStáhnout
2018-10-22 00:00:008-KStáhnout
2018-09-04 01:00:008-KStáhnout
2018-09-04 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-02 01:00:008-KStáhnout
2018-08-02 01:00:0010-QStáhnout
2018-08-02 00:00:008-KStáhnout
2018-08-02 00:00:0010-QStáhnout
2018-06-27 01:00:008-KStáhnout
2018-06-27 00:00:008-KStáhnout
2018-05-09 01:00:008-KStáhnout
2018-05-09 01:00:0010-QStáhnout
2018-05-09 00:00:008-KStáhnout
2018-05-09 00:00:0010-QStáhnout
2018-03-08 00:00:008-KStáhnout
2018-03-08 00:00:0010-KStáhnout
2018-03-07 23:00:008-KStáhnout
2018-03-07 23:00:0010-KStáhnout
2018-01-31 00:00:008-KStáhnout
2018-01-30 23:00:008-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2017-11-08 00:00:008-KStáhnout
2017-11-08 00:00:0010-QStáhnout
2017-11-07 23:00:008-KStáhnout
2017-11-07 23:00:0010-QStáhnout
2017-10-16 01:00:008-KStáhnout
2017-10-16 00:00:008-KStáhnout
2017-08-03 01:00:008-KStáhnout
2017-08-03 01:00:0010-QStáhnout
2017-08-03 00:00:008-KStáhnout
2017-08-03 00:00:0010-QStáhnout
2017-07-10 01:00:008-KStáhnout
2017-07-10 00:00:008-KStáhnout
2017-06-21 01:00:008-KStáhnout
2017-06-21 00:00:008-KStáhnout
2017-06-12 01:00:008-KStáhnout
2017-06-12 00:00:008-KStáhnout
2017-06-09 01:00:008-KStáhnout
2017-06-09 00:00:008-KStáhnout
2017-05-04 01:00:008-KStáhnout
2017-05-04 01:00:0010-QStáhnout
2017-05-04 00:00:008-KStáhnout
2017-05-04 00:00:0010-QStáhnout
2017-03-16 00:00:008-KStáhnout
2017-03-16 00:00:0010-KStáhnout
2017-03-15 23:00:008-KStáhnout
2017-03-15 23:00:0010-KStáhnout
2017-01-31 00:00:008-KStáhnout
2017-01-30 23:00:008-KStáhnout
2016-11-10 00:00:0010-QStáhnout
2016-11-09 23:00:0010-QStáhnout
2016-08-11 01:00:0010-QStáhnout
2016-08-11 00:00:0010-QStáhnout
2016-06-17 01:00:008-KStáhnout
2016-06-17 00:00:008-KStáhnout
2016-05-16 01:00:0010-QStáhnout
2016-05-16 00:00:0010-QStáhnout
2016-03-14 00:00:0010-KStáhnout
2016-03-13 23:00:0010-KStáhnout
2016-02-25 00:00:008-KStáhnout
2016-02-24 23:00:008-KStáhnout
2016-02-04 00:00:008-KStáhnout
2016-02-03 23:00:008-KStáhnout
2016-01-11 00:00:008-KStáhnout
2016-01-10 23:00:008-KStáhnout
2015-11-12 00:00:0010-QStáhnout
2015-11-11 23:00:0010-QStáhnout
2015-11-10 00:00:008-KStáhnout
2015-11-09 23:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 00:00:008-KStáhnout
2015-07-01 01:00:008-KStáhnout
2015-07-01 00:00:008-KStáhnout
preloader